CRISPR Therapeutics AG (CRSP) FCF Margin Growth (1y) (2017 - 2026)
CRISPR Therapeutics AG (CRSP) FCF Margin Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,187.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,525.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -341.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | CRISPR Therapeutics AG | 4.57 Bn | 2.12 Bn | - | -124,304.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -124,304.00 |
| Dec 31, 2025 | -1.06 Mn |
| Sep 30, 2025 | 826,755.00 |
| Jun 30, 2025 | 584,463.00 |
| Mar 31, 2025 | -2.79 Mn |
| Dec 31, 2024 | -8,826.00 |
| Jun 30, 2024 | -1.84 Mn |
| Mar 31, 2024 | 2.16 Mn |
| Dec 31, 2023 | 184.21 Mn |
| Jun 30, 2023 | 10.17 Mn |
| Mar 31, 2023 | 1.50 Mn |
| Dec 31, 2022 | -184.14 Mn |
| Sep 30, 2022 | -7.62 Mn |
| Jun 30, 2022 | -10.20 Mn |
| Mar 31, 2022 | 530,374.00 |
| Dec 31, 2021 | 2.54 Mn |
| Sep 30, 2021 | 3.70 Mn |
| Jun 30, 2021 | 6.57 Mn |
| Mar 31, 2021 | 1.48 Mn |
| Dec 31, 2020 | -2.61 Mn |